Patents by Inventor Janice Brissette

Janice Brissette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Screening for Anti-Graying Agents on the Basis of AFF-4
    Publication number: 20110076303
    Abstract: An objective of the present invention is to provide an anti-graying agent. The present invention provides a method for screening an anti-graying agent whereby a substance that increases expression of AFF-4 in cells is selected by applying a candidate substance to cells in vitro; and, an anti-graying agent containing at least one type of herbal extract selected from the group consisting of Ganoderma lucidum (Fr.) Karst. extract, Panax schinseng Nees extract, Oryza sativa (Rice) Bran extract and Rabdosia japonicus extract selected with this method in an amount effective for increasing expression of AFF-4.
    Type: Application
    Filed: June 25, 2010
    Publication date: March 31, 2011
    Inventors: Tokuro Iwabuchi, Lorin Weiner, Janice Brissette, Jian Li
  • FOXN1 AND PIGMENTATION
    Publication number: 20100247627
    Abstract: The present invention provides methods and compositions for modulating skin pigmentation.
    Type: Application
    Filed: March 30, 2010
    Publication date: September 30, 2010
    Inventors: Janice Brissette, Lorin Weiner, Rong Han, Rebecca Campen
  • Foxn1 and pigmentation
    Patent number: 7687265
    Abstract: The present invention provides methods and compositions for modulating skin pigmentation.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: March 30, 2010
    Assignee: The General Hospital Corporation
    Inventors: Janice Brissette, Lorin Weiner, Rong Han, Rebecca Campen
  • Screening for skin wrinkling modulators
    Patent number: 7192770
    Abstract: The invention features methods of screening for compounds that prevent and/or reduce UVB-induced skin damage, e.g., wrinkles. The method includes identifying an agent that increases or induces the expression, activity or levels of a component of the p21 signal transduction pathway. Also included are methods and compositions for treating UVB-induced skin damage.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: March 20, 2007
    Assignee: The General Hospiatal Corporation
    Inventors: Seishiro Fujii, Paolo Dotto, Rong Han, Janice Brissette
  • Foxn1 and pigmentation
    Publication number: 20050191242
    Abstract: The present invention provides methods and compositions for modulating skin pigmentation.
    Type: Application
    Filed: November 24, 2004
    Publication date: September 1, 2005
    Inventors: Janice Brissette, Lorin Weiner, Rong Han, Rebecca Campen
  • Methods and compositions for preventing skin damage
    Publication number: 20040110203
    Abstract: The invention features methods of screening for compounds that prevent and/or reduce UVB-induced skin damage, e.g., wrinkles. The method includes identifying an agent that increases or induces the expression, activity or levels of a component of the p21 signal transduction pathway. Also included are methods and compositions for treating UVB-induced skin damage.
    Type: Application
    Filed: September 19, 2003
    Publication date: June 10, 2004
    Inventors: Seishiro Fujii, Paolo Dotto, Rong Han, Janice Brissette
  • Tyrosinase assay
    Publication number: 20020192738
    Abstract: A novel assay for tyrosinase.
    Type: Application
    Filed: April 29, 2002
    Publication date: December 19, 2002
    Inventors: Janice Brissette, Rong Han, Lorin Weiner